74 related articles for article (PubMed ID: 24435653)
21. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
[TBL] [Abstract][Full Text] [Related]
22. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
23. A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression.
Nalbandian A; Pang AL; Rennert OM; Chan WY; Ravindranath N; Djakiew D
Differentiation; 2005 Oct; 73(8):385-96. PubMed ID: 16316409
[TBL] [Abstract][Full Text] [Related]
24. Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events.
Sirotnak FM; She Y; Khokhar NZ; Hayes P; Gerald W; Scher HI
Mol Carcinog; 2004 Nov; 41(3):150-63. PubMed ID: 15390081
[TBL] [Abstract][Full Text] [Related]
25. Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells.
Tsui KH; Chang YL; Feng TH; Chung LC; Lee TY; Chang PL; Juang HH
J Mol Endocrinol; 2012 Oct; 49(2):153-63. PubMed ID: 22872134
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
27. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
28. Modulation of CXCL14 (BRAK) expression in prostate cancer.
Schwarze SR; Luo J; Isaacs WB; Jarrard DF
Prostate; 2005 Jun; 64(1):67-74. PubMed ID: 15651028
[TBL] [Abstract][Full Text] [Related]
29. Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.
Coutinho-Camillo CM; Salaorni S; Sarkis AS; Nagai MA
Cancer Genet Cytogenet; 2006 Apr; 166(2):130-8. PubMed ID: 16631469
[TBL] [Abstract][Full Text] [Related]
30. Novel expressed sequences identified in a model of androgen independent prostate cancer.
Quayle SN; Hare H; Delaney AD; Hirst M; Hwang D; Schein JE; Jones SJ; Marra MA; Sadar MD
BMC Genomics; 2007 Jan; 8():32. PubMed ID: 17257419
[TBL] [Abstract][Full Text] [Related]
31. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
Xie C; Jiang XH; Zhang JT; Sun TT; Dong JD; Sanders AJ; Diao RY; Wang Y; Fok KL; Tsang LL; Yu MK; Zhang XH; Chung YW; Ye L; Zhao MY; Guo JH; Xiao ZJ; Lan HY; Ng CF; Lau KM; Cai ZM; Jiang WG; Chan HC
Oncogene; 2013 May; 32(18):2282-91, 2291.e1-7. PubMed ID: 22797075
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
33. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
[TBL] [Abstract][Full Text] [Related]
34. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer.
Narita S; So A; Ettinger S; Hayashi N; Muramaki M; Fazli L; Kim Y; Gleave ME
Clin Cancer Res; 2008 Sep; 14(18):5769-77. PubMed ID: 18794086
[TBL] [Abstract][Full Text] [Related]
35. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
Jiang J; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
Int J Oncol; 2012 May; 40(5):1339-44. PubMed ID: 22293856
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin.
Sánchez AM; Sánchez MG; Malagarie-Cazenave S; Olea N; Díaz-Laviada I
Apoptosis; 2006 Jan; 11(1):89-99. PubMed ID: 16374544
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation.
Tsai MH; Cook JA; Chandramouli GV; DeGraff W; Yan H; Zhao S; Coleman CN; Mitchell JB; Chuang EY
Cancer Res; 2007 Apr; 67(8):3845-52. PubMed ID: 17440099
[TBL] [Abstract][Full Text] [Related]
38. Transcriptome analysis of differentially expressed genes and pathways associated with mitoxantrone treatment prostate cancer.
Li S; Li R; Ma Y; Zhang C; Huang T; Zhu S
J Cell Mol Med; 2019 Mar; 23(3):1987-2000. PubMed ID: 30592148
[TBL] [Abstract][Full Text] [Related]
39. G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells.
Zhou C; Dai X; Chen Y; Shen Y; Lei S; Xiao T; Bartfai T; Ding J; Wang MW
Oncotarget; 2016 Mar; 7(11):12823-39. PubMed ID: 26871479
[TBL] [Abstract][Full Text] [Related]
40. Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells.
Dozmorov MG; Hurst RE; Culkin DJ; Kropp BP; Frank MB; Osban J; Penning TM; Lin HK
Prostate; 2009 Jul; 69(10):1077-90. PubMed ID: 19343732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]